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Abstract
We have previously reported that myo-inositol uptake and metabolism is reduced in human fibroblasts derived from
patients with ataxia telangiectasia (AT). Treating normal fibroblasts with 10^100 WM wortmannin duplicates some of the
phenotypic properties of AT fibroblasts including the decrease in myo-inositol accumulation. In the present study we
examined whether treatment of other types of mammalian cells with wortmannin or LY294002 altered myo-inositol uptake.
Cultured bovine aorta endothelial cells or 3T3-L1 adipocytes were incubated with either wortmannin or LY294002, and
afterwards, myo-inositol uptake and SMIT mRNA levels were determined. Incubating cultured bovine aorta endothelial cells
and 3T3-L1 adipocytes with either wortmannin or LY294002 caused a time- and concentration-dependent decrease in myo-
inositol accumulation that was independent of changes in SMIT mRNA levels. The effect of wortmannin and LY294002 on
myo-inositol accumulation was not due to an increase in myo-inositol secretion. The effect of LY294002 on myo-inositol
accumulation was reversible. Furthermore, the LY294002-induced decrease in myo-inositol accumulation was specific since
the uptake of serine or choline by cultured bovine aorta endothelial cells and 3T3-L1 adipocytes treated with LY294002 was
not significantly decreased. Co-incubation of cultured bovine aorta endothelial cells and 3T3-L1 adipocytes with either
wortmannin or LY294002 and hyperosmotic medium caused a significant decrease in the induction of myo-inositol
accumulation by hyperosmolarity without significantly affecting the hyperosmotic-induced increase in SMIT mRNA levels.
These data suggest that myo-inositol accumulation is regulated post-translationally by wortmannin and LY294002. ß 2000
Published by Elsevier Science B.V.
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1. Introduction
myo-Inositol has several important functions in
mammalian cells. First, in the form of phosphoinosi-
tides it is a component of membranes and plays an
integral role in signal transduction pathways by vir-
tue of release of secondary messengers upon activa-
tion of a phosphoinositide speci¢c phospholipase C
or phosphatidylinositol 3-kinase [1^3]. Second, myo-
inositol functions as an osmolyte, serving to protect
cells exposed to hyperosmotic stress [4]. This protec-
tive role is shared with other osmolytes such as sor-
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bitol, betaine, taurine and glycerophosphorylcholine;
however, these osmolytes may di¡er in their role as
osmotic regulators because of their speci¢c tissue lo-
calization and mechanisms responsible for their ac-
cumulation/metabolism [5,6].
In most mammalian cells the intracellular concen-
tration of myo-inositol is maintained at levels many
times higher than circulating concentrations [7,8].
This gradient is regulated and maintained by a
Na/myo-inositol cotransporter (SMIT) that is
widely expressed in mammalian cells and by an e¥ux
mechanism, which is poorly understood [9,10]. Stud-
ies from our laboratory and others have demon-
strated that maintenance of the intracellular myo-
inositol concentration is a highly regulated process.
In mammalian cells, hyperosmolarity is the most po-
tent means to increase the activity of the SMIT and
thus myo-inositol accumulation [11^13]. The hyper-
osmolarity-induced increase in myo-inositol transport
is dependent on increased transcription of the SMIT
gene [12]. Osmotic regulation of organic osmolytes is
physiologically important to renal cells ; however, we
and others have shown that hyperosmolarity also
regulates SMIT activity and mRNA levels in endo-
thelial, neural and glial cells [11,13^16].
We have previously reported that another stress
factor, tumor necrosis factor-K (TNFK), selectively
reduces Na/myo-inositol cotransporter (SMIT)
mRNA levels and myo-inositol accumulation in cul-
tured large vessel and cerebral microvessel endothe-
lial cells and 3T3-L1 adipocytes [17,18]. The regula-
tion of SMIT mRNA levels and transport activity by
TNFK requires protein synthesis and is associated
with the activation of the transcription factor NF-
UB [17]. Furthermore, we have shown that reversal
of SMIT mRNA levels and transport activity by
placing cells in isotonic medium following hyperos-
motic induction also requires protein synthesis and
the activation of NF-UB [19].
In a series of studies we have shown that glucose is
a competitive inhibitor of myo-inositol transport by
cultured endothelial and neural cells, whereas pro-
longed exposure of cultured neural cells to hypergly-
cemia causes an accumulation of sorbitol and a non-
competitive inhibition of myo-inositol transport
[20,21]. The depletion of myo-inositol in cultured
neural cells by these conditions decreases Na,K-
ATPase activity and resting membrane potential
[22,23]. In diabetic animal models, sorbitol accumu-
lation by nerve tissue and a reciprocal decrease in
myo-inositol levels has been linked to the slowing
of motor nerve conduction velocity and Na,K-
ATPase activity in the sciatic nerve [24^27]. These
latter studies suggest that myo-inositol de¢ciency
may contribute pathologically to diabetes-induced
complications [28].
We have shown that myo-inositol transport and
incorporation into phosphoinositides by human ¢-
broblasts from patients with ataxia telangiectasia
(AT) is impaired compared to age-matched normal
human ¢broblasts [29]. Ataxia telangiectasia is an
autosomal recessive disorder characterized by pro-
gressive cerebellar degeneration, immune de¢ciency,
growth retardation, premature aging, chromosomal
instability, acute sensitivity to ionizing radiation,
and cancer and diabetes predisposition [30^32]. Be-
cause of the many physiologic abnormalities associ-
ated with AT, the product of this gene, ATM, is
considered to be a critical regulator of many cellular
processes [31,33]. ATM is a 350 kDa phosphoprotein
which is primarily, but not exclusively located in the
nucleus [34,35]. Interestingly, a region of the AT gene
has sequence homology to the gene encoding the
p110 catalytic subunit of phosphatidylinositol 3-ki-
nase [36]. Studies with normal murine ¢broblasts
have shown that inhibition of phosphoinositide 3-ki-
nase-related activity with wortmannin sensitizes nor-
mal ¢broblasts to radiation and blocks induction of
p53 following DNA damage [37,38]. We have ob-
served that wortmannin also inhibits myo-inositol
transport by 25% in cultured human ¢broblasts
[29]. At this time we do not know whether ATM
regulates SMIT expression or activity or whether
the cellular conditions created by a de¢ciency of
ATM alters myo-inositol metabolism.
To further explore the relationship between wort-
mannin incubation and myo-inositol accumulation
by mammalian cells we exposed cultured endothelial
cells and 3T3-L1 adipocytes to wortmannin or
LY294002 and then examined the e¡ect on SMIT
mRNA levels and myo-inositol accumulation. The
reason for selecting endothelial cells and 3T3-L1 adi-
pocytes for these studies is that it has been shown
that phosphatidylinositol 3-kinase activity is impor-
tant in regulating signal transduction properties in
these cells, especially in adipocytes, where phospha-
BBAMCR 14656 11-9-00
M.A. Yorek et al. / Biochimica et Biophysica Acta 1497 (2000) 328^340 329
tidylinositol 3-kinase activity has been shown to reg-
ulate insulin action [2].
2. Materials and methods
2.1. Materials
Chemicals were from Sigma (St. Louis, MO) un-
less otherwise noted. Wortmannin and LY294002
were purchased from Calbiochem (La Jolla, CA).
TNFK was purchased from Intergen (Purchase,
NY). Ethanol, chloroform, isoamyl alcohol, Corning
75-cm2 £asks and Falcon 6-well plates were from
Fisher Scienti¢c (Fair Lawn, NJ). Phenol was from
Bethesda Research Laboratories (Gaithersburg,
MD). Ethidium bromide and proteinase K were
from Boehringer-Mannheim (Indianapolis, IN). So-
dium dodecyl sulfate (SDS) was from BDH (Poole,
England). Pyridine, trimethylchlorosilane and hexa-
methyldisilazane were from Pierce (Rockford, IL).
Acrylamide, bis-acrylamide, dextran sulfate, and
N,N,NP,NP-tetramethylethylenediamine were from
Biorad (Hercules, CA). Transcription bu¡er, dithio-
threitol, RNasin, ATP, CTP, UTP, GTP, T7 and
SP6 RNA polymerase and deoxyribonuclease were
from Promega (Madison, WI). myo-[2-3H]Inositol,
L-[U-14C]serine, [methyl-3H]choline chloride, [Q-32P]-
ATP and [32P]UTP were from Amersham (Arlington
Heights, IL). Safety-Solve, cesium chloride and scin-
tillation vials were from RPI (Mount Prospect, IL).
cDNA probes for the L-actin gene was obtained
from Ambion (Austin, TX). Phosohotyrosine-PY20
antibody was from Transduction Laboratories (Lex-
ington, KY) and Protein AG agarose was from San-
ta Cruz Biotechnology (Santa Cruz, CA). Media
were obtained from the Diabetes Endocrinology Re-
search Center, University of Iowa (Iowa City, IA).
2.2. Cell culture
Bovine aortic endothelial cells (BAE) originated
from freshly slaughtered steers and were grown in
Dulbecco’s minimal essential medium (DMEM) sup-
plemented with 10% heat-inactivated fetal bovine se-
rum, 100 U/ml penicillin, 100 Wg/ml streptomycin,
and 294 Wg/ml glutamine [11]. Cells were passed
weekly 1:10 using trypsin/EDTA and fed twice per
week by replacing the medium. Murine 3T3-L1 ¢bro-
blasts were obtained from the American Type Cul-
ture Collection (Rockville, MD). Cells were cultured
DMEM with high glucose supplemented with 10%
calf serum, 100 U/ml penicillin, 100 Wg/ml streptomy-
cin, and 294 Wg/ml glutamine. To di¡erentiate, pre-
adipocytes were allowed to grow 2 days past con£u-
ency and then cultured for 4 days with one change in
each of the following three media: (1) DMEM with
high glucose supplemented with 10% fetal bovine se-
rum, 100 U/ml penicillin, 100 Wg/ml streptomycin,
294 Wg/ml glutamine, 1 mg/l insulin, 100 Wg/l dexa-
methasone, and 111 mg/l isobutylmethylxanthine; (2)
DMEM with high glucose supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, 100 Wg/ml
streptomycin, 294 Wg/ml glutamine, and 1 mg/l insu-
lin; (3) DMEM with high glucose supplemented with
10% fetal bovine serum, 100 U/ml penicillin, 100 Wg/
ml streptomycin, and 294 Wg/ml glutamine [18]. Dif-
ferentiated 3T3-L1 adipocytes were used for the fol-
lowing studies within 2 days of completion of the
di¡erentiation procedure.
2.3. myo-Inositol accumulation
For determination of myo-inositol accumulation,
endothelial cells or 3T3-L1 adipocytes were incu-
bated in serum-free medium containing 0.5% bovine
serum albumin (BSA) for 1^24 h in the absence or
presence of vehicle (0.1% DMSO), 0.1^10 WM wort-
mannin (stock 10 mM in DMSO), 0.5^50 WM
LY294002 (stock 100 mM in DMSO), 20 ng/ml
TNFK or 175 mM ra⁄nose to induce hyperosmolar-
ity as described previously [11]. For these studies
incubation with TNFK or hyperosmotic medium
were conducted for comparison to the studies with
wortmannin and LY294002. Studies were also con-
ducted in which endothelial cells or 3T3-L1 adipo-
cytes were co-incubated with wortmannin or
LY294002 and hyperosmotic medium to determine
the in£uence of the combination of the phosphatidyl-
inositol 3-kinase inhibitors with hyperosmolarity on
myo-inositol accumulation. Following these incuba-
tions the cells were washed with serum-free medium
and myo-inositol accumulation determined after a
1-h incubation in serum-free medium containing
11.4 WM myo-[2-3H]inositol in absence of inhibitors.
In these studies, ‘myo-inositol accumulation’ repre-
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sents the cellular accumulation of radioactivity de-
rived from myo-[2-3H]inositol during the 1-h incuba-
tion and does not represent the initial rate of myo-
inositol transport by the cells, nor does it account for
any myo-[2-3H]inositol taken up by the cells then
secreted during the 1-h incubation period. Serine
and choline accumulation were determined as de-
scribed for myo-inositol accumulation.
2.4. Phosphatidylinositol 3-kinase assay
For the phosphatidylinositol 3-kinase assay, cell
lysates (0.5 mg) were ¢rst immunoprecipitated over-
night with phosphotyrosine-PY20 antibody (1 Wg)
followed by 2 h incubation with protein AG-agarose.
After washing the immunoprecipitates were assayed
as described by Heart et al. in a reaction cocktail
containing phosphatidylinositol as substrate and
[Q-32P]ATP [39]. Phosphatidylinositol 3-phosphate, a
reaction product, was separated by thin layer chro-
matography and afterwards collected from the thin
layer plate and counted in a liquid scintillation coun-
ter.
2.5. RNA isolation and quanti¢cation of SMIT
mRNA levels
RNA was prepared using the guanidine isothio-
cyanate-cesium chloride method. RNA was quanti-
tated by measuring the absorbance at 260 nm, and
the integrity of the RNA and accuracy of quanti¢ca-
tion were con¢rmed by size separating the RNA by
denaturing gel electrophoresis and comparing the in-
tensity of the 18S and 28S ribosomal RNA bands
after ethidium bromide staining of the gel [11].
SMIT mRNA levels in endothelial cells and 3T3-L1
adipocytes were quanti¢ed using a solution hybridi-
zation^RNase protection assay as previously de-
scribed [1,30]. Brie£y, for 3T3-L1 adipocytes, 32P-la-
beled antisense SMIT mRNAs were transcribed
using T7 RNA polymerase and a murine SMIT
cDNA construct in pGEM-3Zf(+) that had been lin-
earized with HindIII [25,26]. Due to the high degree
of homology of the SMIT gene, the 32P-labeled anti-
sense murine SMIT mRNA probe also hybridized to
bovine RNA resulting in a protected band similar in
size to the protected RNA band that was obtained
using RNA prepared from murine cells. Thus, the
same procedure was used to determine SMIT
mRNA levels in BAE cells [11]. Details of the clon-
ing of the murine SMIT cDNAs have been described
previously [11]. Antisense SMIT mRNA was incu-
bated at 45‡C in 75% formamide^0.4 M NaCl with
20 Wg of total RNA. After 16 h incubation, the sam-
ples were digested with RNases A and T1. The pro-
tected double-stranded hybrids were collected by
ethanol precipitation and electrophoresed through
an 8% polyacrylamide^8 M urea denaturing gel. To
con¢rm equal loading of the gel, L-actin mRNA lev-
els were determined simultaneously with the use of
commercially available L-actin antisense control tem-
plates. The antisense L-actin RNA probes were gen-
erated per the manufacturer’s instructions using T7
polymerase. A su⁄cient quantity of each of the anti-
sense SMIT mRNA and L-actin probes was added to
each sample to insure the presence of an excess of
labeled antisense RNA. SMIT mRNA was repre-
sented as a single band on the autoradiogram of
the gel with the intensity of the band being propor-
tional to the SMIT mRNA level in the sample. SMIT
mRNA levels were quanti¢ed by scanning densitom-
etry of the autoradiogram using a GS 300 transmit-
tance/re£ectance scanning densitometer (Hoefer, San
Francisco, CA) interfaced with a model HP 3396A
integrator and standardized to the intensity of the
L-actin mRNA band.
2.6. Data analysis
Data for myo-inositol accumulation are reported
as nmol per milligram cell protein. Signi¢cance of
di¡erences was determined by ANOVA and Stu-
dent’s t-test. For analysis of SMIT mRNA levels,
statistical comparisons for signi¢cance were per-
formed using the one-tailed multiple comparison
procedure of Dunnett.
3. Results
In order to determine the e¡ect of wortmannin
and LY294002 on myo-inositol accumulation by cul-
tured endothelial cells and adipocytes, we incubated
bovine aorta endothelial cells and 3T3-L1 adipocytes
in medium containing 1% fetal bovine serum for 16 h
and 0^10 WM wortmannin or 0^50 WM LY294002
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(Fig. 1). For comparison we also incubated endo-
thelial cells and 3T3-L1 adipocytes in medium con-
taining 20 ng/ml TNFK. Afterwards, myo-inositol
accumulation was determined. Data in Fig. 1 dem-
onstrate that wortmannin and LY294002 cause a
concentration dependent decrease in myo-inositol
accumulation by bovine aorta endothelial cells and
3T3-L1 adipocytes. Wortmannin (1.0 WM) and
LY294002 (5.0 WM) caused a signi¢cant inhibition
of myo-inositol accumulation by cultured bovine aor-
ta endothelial cells. In 3T3-L1 adipocytes, signi¢cant
inhibition of myo-inositol accumulation was achieved
with 0.1 WM wortmannin and 0.5 WM LY294002.
Inhibition of myo-inositol accumulation by 10 WM
wortmannin and 50 WM LY294002 was similar to
the inhibition of myo-inositol accumulation observed
with TNFK. A time course study using 10 WM wort-
mannin and 25 WM LY294002 demonstrated that in-
hibition of myo-inositol accumulation by cultured
bovine aorta endothelial cells required an incubation
period of 8 h with wortmannin or LY294002, where-
as in 3T3-L1 adipocytes incubation periods of 24 h
and 8 h, respectively, were required for signi¢cant
inhibition of myo-inositol accumulation by wortman-
nin and LY294002 (Fig. 2). No inhibition of myo-
inositol accumulation by cultured bovine aorta endo-
thelial cells or 3T3-L1 adipocytes was observed fol-
lowing a 1-h incubation with either wortmannin or
LY294002. As described previously, incubation with
TNFK caused a similar time-dependent inhibition of
myo-inositol accumulation by cultured bovine aorta
endothelial cells and 3T3-L1 adipocytes [17,18]. In
another study we found that co-incubating cultured
bovine aorta endothelial cells or 3T3-L1 adipocytes
with 10 WM wortmannin and 25 WM LY294002 did
not have an additive e¡ect on the inhibition of myo-
inositol accumulation when compared to the e¡ect of
these inhibitors alone on myo-inositol accumulation
(data not shown).
As expected, wortmannin (1^10 WM) and
Fig. 1. Concentration-dependent e¡ect of wortmannin and LY294002 on myo-inositol accumulation by bovine aorta endothelial cells
(BAE) and 3T3-L1 adipocytes (3T3-L1). Cells were incubated in medium containing 0.5% bovine serum albumin for 16 h in the ab-
sence or presence of 20 ng/ml TNFK, 0.1^10.0 WM wortmannin, or 0.5^50.0 WM LY294002. Afterwards, the cells were washed and in-
cubated for 1 h in serum-free medium containing 11.4 WM myo-inositol and myo-[2-3H]inositol to determine myo-inositol accumula-
tion. The data are presented as the mean þ S.E.M. for nine and 12 separate experiments for BAE and 3T3-L1, respectively. *P6 0.05
compared to control.
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LY294002 (5^25 WM) completely inhibited phospha-
tidylinositol 3-kinase activity. In bovine aorta endo-
thelial cells 10 WM PDGF increased phosphatidylino-
sitol 3-kinase activity by more than 2-fold and was
totally inhibited by either wortmannin or LY294002.
Similar results were obtained with 3T3-L1 adipo-
cytes. Insulin (100 nM) increased phosphatidylinosi-
tol 3-kinase activity by approximately 9.5-fold, and
wortmannin and LY294002 inhibited insulin stimu-
lation by 72% and 85%, respectively.
We next examined the speci¢city of the e¡ect of
LY294002 on myo-inositol accumulation. In this
study we determined the e¡ect of a 16 h incubation
with 25 WM LY294002 on the accumulation of myo-
inositol, serine and choline by cultured bovine aorta
endothelial cells or 3T3-L1 adipocytes. These studies
demonstrated that in cultured bovine endothelial
cells LY294002 caused a 3% and 13% reduction in
serine and choline accumulation, respectively. In
comparison, myo-inositol accumulation was reduced
by 46%. Similar results were obtained with 3T3-L1
adipocytes. LY294002 caused a non-signi¢cant de-
crease in serine and choline accumulation of 27%
and 16%, respectively, whereas myo-inositol accumu-
lation was reduced by 78%. These studies suggest
that the e¡ect of LY294002 on myo-inositol accumu-
lation by cultured bovine aorta endothelial cells or
3T3-L1 adipocytes is speci¢c when compared to the
accumulation of two other compounds utilized for
membrane synthesis.
Data presented in Fig. 3 demonstrate that the
LY294002-induced inhibition of myo-inositol accu-
mulation by cultured bovine aorta endothelial cells
and 3T3-L1 adipocytes was reversible. As described
above, incubating cultured bovine aorta endothelial
cells or 3T3-L1 adipocytes with 25 WM LY294002 for
16 h caused a signi¢cant inhibition of myo-inositol
accumulation. When cultured bovine aorta endothe-
lial cells or 3T3-L1 adipocytes were preincubated for
16 h in medium containing 25 WM LY294002 and
then washed and incubated in normal medium for
6 h, myo-inositol accumulation was signi¢cantly im-
Fig. 2. Time-dependent e¡ect of wortmannin and LY294002 on myo-inositol accumulation by bovine aorta endothelial cells (BAE)
and 3T3-L1 adipocytes (3T3-L1). Cells were incubated in medium containing 0.5% bovine serum albumin for 1, 8 or 24 h in the ab-
sence or presence of 20 ng/ml TNFK, 10.0 WM wortmannin, or 25.0 WM LY294002. Afterwards, the cells were washed and incubated
for 1 h in serum-free medium containing 11.4 WM myo-inositol and myo-[2-3H]inositol to determine myo-inositol accumulation. The
data are presented as the mean þ S.E.M. for six separate experiments. *P6 0.05 compared to control.
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proved and returned to normal range within 24 h. In
another study we examined whether incubation with
wortmannin or LY294002 increased the secretion of
myo-inositol from cells. In these studies cultured bo-
vine aorta endothelial cells or 3T3-L1 adipocytes
were prelabeled with myo-[2-3H]inositol for 16 h
and washed and incubated in normal medium or
medium containing 10 WM wortmannin or 50 WM
LY294002 for up to 24 h. These studies demon-
strated that myo-[2-3H]inositol secretion from the
cells was not increased by incubation with either
wortmannin or LY294002 (data not shown), suggest-
ing that the inhibition of myo-inositol accumulation
by wortmannin or LY294002 is not due to increased
myo-inositol secretion by the cells.
To further examine the e¡ect of wortmannin or
LY294002 on myo-inositol metabolism, we investi-
gated their e¡ect on SMIT mRNA levels. Data in
Fig. 4 demonstrate, as previously shown, that hyper-
osmolarity signi¢cantly increased SMIT mRNA lev-
els and myo-inositol accumulation (Table 1) by cul-
tured bovine aorta endothelial cells and 3T3-L1
adipocytes [11,18]. In contrast, TNFK caused a sig-
ni¢cant decrease in SMIT mRNA levels and myo-
inositol accumulation by these cells [17,18]. Even
though the e¡ect of wortmannin and LY294002 on
myo-inositol accumulation is similar to that of
TNFK, they were found to have no e¡ect on SMIT
mRNA levels (Fig. 4). SMIT mRNA levels in cul-
tured bovine aorta endothelial cells and 3T3-L1 adi-
pocytes were unchanged compared to control follow-
ing a 16 h incubation with either wortmannin or
LY294002. Therefore, the reduction in myo-inositol
accumulation induced by TNFK compared to wort-
mannin or LY294002 must be mediated by di¡erent
mechanisms. We also examined the e¡ect of wort-
mannin and LY294002 on hyperosmolarity-induced
SMIT mRNA levels and myo-inositol accumulation
Fig. 3. Reversal of the e¡ect of LY294002 on myo-inositol accumulation by bovine aorta endothelial cells (BAE) and 3T3-L1 adipo-
cytes (3T3-L1). Cells were preincubated in medium containing 0.5% bovine serum albumin and 25 WM LY294002 for 24 h. Following
the preincubation, cells were washed and incubated for an additional 1^24 h in medium without inhibitor. Afterwards, the cells were
washed and incubated for 1 h in serum-free medium containing 11.4 WM myo-inositol and myo-[2-3H]inositol to determine myo-inosi-
tol accumulation. Control cells were incubated for the entire 48 h in medium containing 0.5% bovine serum albumin. Cells exposed to
LY294002 alone were incubated for 24 h in medium containing 0.5% bovine serum albumin and 25 WM LY294002. The data are pre-
sented as the mean þ S.E.M. for eight separate experiments. *P6 0.05 compared to control.
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(Fig. 4 and Table 1). Data in Fig. 4 demonstrate that
co-incubating cultured bovine aorta endothelial cells
and 3T3-L1 adipocytes with 20 ng/ml TNFK and
175 mM ra⁄nose (to induce hyperosmolarity) mark-
edly attenuated the induction of SMIT mRNA levels
and signi¢cantly decreased myo-inositol accumula-
tion compared to hyperosmolarity alone. Similar to
the e¡ect of TNFK, co-incubation of cultured bovine
aorta endothelial cells and 3T3-L1 adipocytes with
10 WM wortmannin or 25 WM LY294002 and 175
mM ra⁄nose caused a signi¢cant decrease in the
induction of myo-inositol accumulation by hyperos-
molarity. However, neither wortmannin nor
LY294002 caused a consistent decrease in the induc-
tion of SMIT mRNA levels by hyperosmolarity. The
inhibitory e¡ect of wortmannin on the induction of
SMIT mRNA levels by hyperosmolarity was signi¢-
cant for cultured bovine aorta endothelial cells but
not 3T3-L1 adipocytes.
4. Discussion
Previously we and others have shown that the
transport of myo-inositol by mammalian cells is regu-
lated by several di¡erent stress factors. The transcrip-
tion of the gene encoding the Na-dependent myo-
inositol cotransporter (SMIT) is increased by hyper-
osmolarity, and, following exposure to hyperosmotic
conditions, many cells have been shown to increase
myo-inositol accumulation suggesting that myo-inosi-
tol is an important organic osmolyte [11^16,40,41].
Following removal of the hyperosmotic stress, SMIT
mRNA levels and, subsequently, cellular myo-inosi-
tol content and transport rapidly return to normal
[11,14^16,19]. Returning cells from a hyperosmotic
to isotonic medium has been shown to activate a
myo-inositol e¥ux pathway that is Na-independent
and inhibited by quinidine, quinine, anion transport
blockers and cis-unsaturated fatty acids [42^44]. In
Fig. 4. E¡ect of wortmannin and LY294002 on Na-dependent myo-inositol transporter (SMIT) mRNA levels in bovine aorta endo-
thelial cells (BAE) and 3T3-L1 adipocytes (3T3-L1). Cells were incubated in medium containing 0.5% bovine serum albumin for 24 h
in the absence or presence of 20 ng/ml TNFK, 10.0 WM wortmannin (wort), or 25.0 WM LY294002 (LY). To determine the e¡ect of
TNFK, wortmannin or LY294002 on hyperosmolarity-induced SMIT mRNA levels cells were co-incubated in medium containing 175
mM ra⁄nose (to induce hyperosmolarity) in the absence of presence of TNFK, wortmannin or LY294002. After these incubations,
RNA was isolated, and SMIT and L-actin mRNA levels determined as described in Section 2. The data are presented as the percent-
age of control with SMIT mRNA levels present in control cells assigned a value of 100%. Each experiment was conducted six sepa-
rate times. *P6 0.05, greater than control; P6 0.05, less than control ; #P6 0.05, less than hyperosmolarity-induced cells.
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previous studies, we have shown that post-induction
normalization of hyperosmolarity-induced SMIT
mRNA levels and myo-inositol transporter activity
is accompanied by the activation of NF-UB and re-
quires RNA and protein synthesis [19,45]. We have
also shown that the activation of NF-UB by the cy-
tokine TNFK regulates the mRNA levels and trans-
port activity of the SMIT [17,18]. In studies with
cultured bovine aorta endothelial cells and 3T3-L1
adipocytes, we demonstrated that TNFK activates
NF-UB and causes a decrease in SMIT mRNA levels
and myo-inositol accumulation. Blocking the activa-
tion of NF-UB prevented the decrease in SMIT
mRNA levels and myo-inositol accumulation medi-
ated by TNFK. Additional factors have been sug-
gested to regulate myo-inositol transport by mamma-
lian cells. Preston et al. [46] in studies with MDCK
cells demonstrated that activators of protein kinase
A or protein kinase C reduce myo-inositol uptake in
cells exposed to either isotonic or hypertonic condi-
tions. However, there are con£icting reports regard-
ing the possible role of protein kinase C in the post-
translational regulation of SMIT activity. Guzman
and Crews [47] have reported that hyperglycemia in-
creases myo-inositol transport in cultured mesangial
cells by a mechanism mediated by the activation of
protein kinase C. Furthermore, we have shown that
phorbol myristate acetate (PMA), an activator of
protein kinase C, did not a¡ect myo-inositol uptake
by 3T3-L1 adipocytes [18]. Therefore, the role that
activation of protein kinase A or C has in regulating
myo-inositol transport may be cell speci¢c.
In the present studies we describe another mecha-
nism by which myo-inositol transport may be regu-
lated by mammalian cells. These studies demon-
strated that incubating cultured bovine aorta
endothelial cells or 3T3-L1 adipocytes with wort-
mannin or LY294002 caused a concentration- and
time-dependent decrease in myo-inositol accumula-
tion. Unlike the e¡ect of TNFK on reducing myo-
inositol accumulation, treatment with wortmannin
and LY294002 did not decrease SMIT mRNA levels.
Therefore, it appears that wortmannin and
LY294002 cause a posttranslational modi¢cation of
myo-inositol transport activity. In addition to the in-
hibition of myo-inositol accumulation by wortman-
nin and LY294002, these inhibitors also attenuated
hyperosmolarity-induced myo-inositol accumulation
by cultured bovine aorta endothelial cells and 3T3-
L1 adipocytes without consistently reducing the in-
duction of SMIT mRNA levels by hyperosmolarity.
Incubating cultured bovine aorta endothelial cells
and 3T3-L1 adipocytes with LY294002 did not de-
crease serine or choline accumulation and the inhib-
itory e¡ect of LY294002 on myo-inositol accumula-
tion was reversible. Therefore, the e¡ects of these
inhibitors on myo-inositol accumulation does not ap-
pear to be due to a general reduction in cellular
transport properties or uptake of substrates for
membrane synthesis. Furthermore, neither wortman-
nin nor LY294002 increased myo-inositol secretion
by the cells.
At present, evidence for an involvement of phos-
phatidylinositol 3-kinases in a given biological sys-
tem is obtained from treating cells with 5^25 WM
LY294002 or 20^50 nM wortmannin [48]. Wortman-
nin and LY294002 are structurally unrelated, cell-
permeable, compounds that are, at low doses, rather
speci¢c inhibitors of most phosphatidylinositol 3-ki-
nases [48]. At higher concentrations, however, these
Table 1
myo-Inositol accumulation by cultured endothelial cells and
3T3-L1 adipocytes: e¡ect of hyperosmolarity with or without
TNFK, wortmannin or LY294002
Conditions Cells (nmol/mg protein)
BAE (9) 3T3-L1 (12)
Control 0.57 þ 0.09 1.24 þ 0.09
Hyperosmolarity 4.87 þ 0.44a 3.53 þ 0.43a
TNFK 0.24 þ 0.02b 0.62 þ 0.07b
Wortmannin 0.26 þ 0.02b 0.63 þ 0.06b
LY294002 0.20 þ 0.01b 0.22 þ 0.02b
Hy+TNFK 2.52 þ 0.37a;c 1.30 þ 0.15c
Hy+Wort 2.05 þ 0.38a;c 1.74 þ 0.23c
Hy+LY 1.23 þ 0.26a;c 1.31 þ 0.08c
Cells were incubated for 16 h in serum-free medium containing
175 mM ra⁄nose to induce hyperosmolarity, 20 ng/ml TNFK,
10 WM wortmannin (Wort), 25 WM LY294002 (LY) or the com-
bination of 175 mM ra⁄nose (Hy) with or without TNFK,
wortmannin or LY294002. The data are expressed as the
mean þ S.E.M. The number of experimental observations is in-
dicated in parentheses.
aIncrease in myo-inositol accumulation compared to control,
P6 0.05.
bDecrease in myo-inositol accumulation compared to control,
P6 0.05.
cDecrease in myo-inositol accumulation compared to hyperos-
molarity-treated cells, P6 0.05.
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compounds lose speci¢city and are capable of inhib-
iting phosphatidylinositol 4-kinase, phospholipase
A2, protein kinase C and phospholipase D [48,49].
Wortmannin binds covalently to the phosphatidyl-
inositol 3-kinase catalytic subunits, a reaction that
is competed by ATP and phosphatidylinositol-(4,5)-
bisphosphate, whereas LY294002 is a competitive in-
hibitor of the ATP site [48]. Classes I, II, and III of
the phosphatidylinositol 3-kinases show a similar in
vitro sensitivity to wortmannin and LY294002 [48].
However, the phosphatidylinositol 3-kinases of class
IV are generally less sensitive to wortmannin than
LY294002 [48]. The phosphatidylinositol 3-kinases
in this class include rapamycin (TOR), DNA-depen-
dent protein kinase (DNA-PK) and ataxia telangiec-
tasia mutated (ATM) [48]. Furthermore, wortman-
nin, in contrast to LY294002, is unstable in
aqueous solutions [48]. This makes it di⁄cult to as-
sess the doses of active drug when applied to cells in
tissue culture for periods longer than a couple of
hours [48]. In our studies, the concentration of wort-
mannin required to inhibit myo-inositol accumula-
tion was higher by about two orders of magnitude
then is generally used to inhibit phosphatidylinositol
3-kinase activity of classes I^III (10 WM vs. 100 nM).
This may be due to a loss of wortmannin activity
during the extended incubation period or that the
phosphatidylinositol 3-kinase like enzyme responsi-
ble for regulating myo-inositol accumulation is a
class IV phosphatidylinositol 3-kinase. Another ex-
planation is that the non-speci¢c e¡ect of these in-
hibitors when present at high concentrations on pro-
tein kinase C, phospholipase A2, and phospholipase
D activity is responsible for decreasing myo-inositol
accumulation. However, previous studies with cul-
tured endothelial cells and 3T3-L1 adipocytes have
shown that inhibition of protein kinase C or phos-
pholipase A2 activity does not a¡ect myo-inositol
accumulation [17,18]. Therefore, it is unlikely that
the non-speci¢c e¡ect of wortmannin or LY294002
on protein kinase C or phospholipase A2 activity is
responsible for inhibiting myo-inositol accumulation.
We do not know whether the inhibition of myo-ino-
sitol accumulation caused by wortmannin or
LY294002 is due to a direct e¡ect on the myo-inosi-
tol transporter or due to a secondary inhibition of a
protein required for maintaining normal myo-inositol
transporter activity.
In a previous study, we demonstrated that myo-
inositol transport is reduced in human ¢broblasts
from patients with ataxia telangiectasia compared
to age-matched normal ¢broblasts [29]. As discussed
above, ¢broblasts as well as other cell types from
patients with ataxia telangiectasia are sensitive to
ionizing radiation [37,38,50,51]. Incubating normal
¢broblasts with 10^100 WM wortmannin induces ra-
diation sensitivity similar to ¢broblasts from patients
with ataxia telangiectasia [37,38]. Accumulation of
myo-inositol is also reduced by treating normal hu-
man ¢broblasts with 20 WM wortmannin [29]. There-
fore, treating normal ¢broblasts with a high concen-
tration of wortmannin, several orders of magnitude
greater then is required to inhibit phosphatidylinosi-
tol 3-kinase activity, creates a phenotype that is sim-
ilar to ataxia telangiectasia with respect to radiation
sensitivity and myo-inositol accumulation. The pro-
tein encoded by the AT gene has sequence homology
to the p110 catalytic subunit of phosphatidylinositol
3-kinase and belongs in class IV of the phosphatidyl-
inositol 3-kinases [36]. However, to date, no one has
shown that the AT gene product is a lipid kinase.
Rather it is more likely that the AT gene product
is a protein kinase at a crossroad of signal transduc-
tion regulation important in cell cycle control and
DNA damage surveillance [52]. It is possible that
the AT gene product or one of several other phos-
phoinositide 3-kinase-related kinases from the class
IV category such as mammalian DNA-PK, TOR,
Rad3-related protein (ATR) and FRAP may regulate
basal myo-inositol transport [34,52^54]. Consistent
with this possibility, it has been shown that both
AT protein and DNA-PK activity are inhibited by
high concentrations of wortmannin [38].
Spizz and Pike have shown that myo-inositol up-
take and incorporation into phosphoinositides by
BC3H1 cells is reduced when the cells are di¡erenti-
ated by serum withdrawal [55]. The decrease in myo-
inositol uptake was corrected when puri¢ed growth
factors such as TGF-L, EGF and FGF were added
to the serum-free medium. Many growth factors ac-
tivate phosphatidylinositol 3-kinase activity [2].
Therefore, it is possible that the activation of phos-
phatidylinositol 3-kinase activity by the addition of
these growth factors restored basal myo-inositol up-
take and metabolism. However, in our studies, we
treated 3T3-L1 adipocytes with PDGF and insulin,
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known activators of phosphatidylinositol 3-kinase
activity, and found no e¡ect on myo-inositol accu-
mulation (data not shown). Therefore, it seems un-
likely that activation of phosphatidylinositol 3-kinase
activity contributes to the regulation of myo-inositol
transport in endothelial cells or adipocytes. It is pos-
sible that the increase in myo-inositol uptake stimu-
lated by TGF-L, EGF, and FGF may be mediated
by the activation of a phosphatidylinositol 3-kinase
like protein from the class IV family.
In summary, we have previously shown that, in
endothelial cells and 3T3-L1 adipocytes, stress fac-
tors such as hyperosmolarity and TNFK have con-
trasting e¡ects on the regulation of SMIT mRNA
levels and transporter activity. In the present studies,
we demonstrate that wortmannin and LY294002 de-
crease myo-inositol accumulation independent of an
e¡ect on SMIT mRNA levels. These studies imply
that other cellular proteins contribute to the regula-
tion of myo-inositol transport and may impact on
membrane synthesis and/or signal transduction path-
ways that rely on phosphoinositides.
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